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Abstract
 
Intrathymic self-peptide–major histocompatibility complex class II (MHC) molecules shape the
T cell repertoire through positive and negative selection of immature CD4
 
1
 
CD8
 
1
 
 thymocytes.
By analyzing the development of MHC class II–restricted T cell receptor (TCR) transgenic T
cells under conditions in which the endogenous peptide repertoire is altered, we show that self-
peptide–MHC complexes are also involved in setting T cell activation thresholds. This occurs
through changes in the expression level of molecules on thymocytes that influence the sensitiv-
ity of TCR signaling. Our results suggest that the endogenous peptide repertoire modulates T
cell responsiveness in the thymus in order to enforce tolerance to self-antigens.
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Introduction
 
The formation of a useful T cell repertoire that can re-
spond to foreign antigens while remaining nonresponsive
to self begins in the thymus where immature T cell pre-
cursors expressing unique antigen receptors are screened
for their ability to interact with self-MHC ligands. Thy-
mocytes that express a TCR capable of engaging self-
MHC molecules with low avidity are positively selected
to form the peripheral T cell compartment, while those
with TCRs that bind to self-MHC ligands too strongly
are deleted to prevent the maturation of autoreactive
clones (1). The composition of self-peptides bound to in-
trathymic MHC molecules heavily influences the selec-
tion process (2). Fetal thymic organ culture systems using
MHC class I–restricted TCR transgenic thymocytes have
 
shown that positive selection of CD8
 
1
 
 T cells is facilitated
by specific class I–binding peptides (3, 4). Moreover, vari-
ous mutant and transgenic strains of mice engineered to
express a severely limited array of self-peptides on MHC
class II exhibit defects in producing a diverse CD4
 
1
 
 T cell
repertoire (5–7). These experiments indicate that the sig-
nals that drive positive selection of a given thymocyte are
delivered by specific self-peptides bound to thymic MHC
molecules.
Once these signals are received, immature CD4
 
1
 
CD8
 
1
 
double positive (DP)
 
1
 
 thymocytes undergo a variety of
phenotypic and functional changes. These include upregu-
lation of the surface expression of the TCR and activation
markers such as CD69 and CD5 (8–11). Other matura-
tional changes induced in positively selected thymocytes
include downregulation of the recombination activating
gene (RAG) products involved in TCR gene rearrange-
ment (12–17) and commitment to either the CD4
 
1
 
 or
CD8
 
1
 
 single positive (SP) lineage. Furthermore, changes in
the signaling properties of the TCR occur such that mature
T cells become less sensitive to TCR stimulation (18, 19).
Studies of the changes that occur during thymocyte mat-
uration have primarily focused, to date, on the events sur-
rounding positive selection by specific intrathymic self-
peptides, with the presumption that nonselecting peptides
are ignored and play no role in development. Because a
wide range of affinities theoretically exists for TCR–ligand
interactions in the thymus, we reasoned that for a given
TCR there should exist self-peptides that fall just below the
threshold for positive selection that may still deliver signals
that can induce alterations in thymocyte phenotype or
function. Since thymocytes may be more sensitive to TCR
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b
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variant chain; PerCP, peridinin chlorophyll protein; RAG, recombina-
tion activating gene; SP, single positive. 
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stimulation during the early stages of positive selection,
they may more readily perceive weak signals from such
peptides. Moreover, recent studies indicate that T cell mat-
uration may involve multiple TCR engagements with in-
trathymic ligands that each induce incremental changes in
thymocyte phenotype (20–24). We hypothesized that at
least some of these signals may come from TCR interac-
tion with a broad range of intrathymic peptides that include
those outside the window of avidity for positive selection.
In this study, we tested this hypothesis by analyzing the
phenotype and function of TCR transgenic thymocytes
developing in the presence of altered repertoires of MHC
class II–bound peptides. We present evidence for signals
distinct from those that induce complete positive selection
that can be perceived through the TCR of immature thy-
mocytes. These signals are not sufficient for promoting full
development to the mature SP stage but are able to alter
the expression of molecules such as CD5 and CD2 that are
normally associated with positive selection, and increase
the signaling threshold through the TCR. The expression
levels of these molecules are directly influenced by the en-
dogenous peptide diversity. Our results suggest that imma-
ture 
 
ab 
 
TCR
 
1
 
 thymocytes perceive a broader range of
thymic self-peptide–MHC complexes than previously
thought and adjust the signaling properties of the TCR in
response to the self-peptide repertoire. This may be im-
portant for enforcing the peptide specificity of T cell re-
sponses and maintaining tolerance to the self-peptide rep-
ertoire.
 
Materials and Methods
 
Animals.
 
6–8-wk-old female C57BL/6J (B6, H-2
 
b
 
) and in-
variant chain–deficient B6 mice were purchased from The Jack-
son Laboratory and maintained at the animal facility at the Uni-
versity of Washington. RAG-deficient mice (H-2
 
b
 
) were
purchased from Taconic Farms. H-2M–deficient mice (H-2
 
b
 
)
were provided by Luc Van Kaer (Vanderbilt University, Nash-
ville, TN). TCli TCR transgenic mice were generated as de-
scribed previously (25). Triple peptide transgenic mice were gen-
erated using constructs described elsewhere (7, 26). In brief,
purified human invariant chain (Ii)-peptide DNA constructs were
coinjected into (B6 
 
3
 
 DBA/2) F1 
 
3 
 
Ii
 
2
 
/
 
2
 
 embryos. Germline
transmission of constructs was verified by PCR amplification of
tail DNA from the progeny of transgenic founders using primers
specific for each transgene. Triple peptide mice were further bred
to homozygous Ii
 
2
 
/
 
2
 
, Ii
 
2
 
/
 
2
 
 
 
H-2M
 
2
 
/
 
2
 
, or RAG
 
2
 
/
 
2
 
 
 
backgrounds.
TCliRAG
 
2
 
/
 
2
 
 
 
Ii
 
2
 
/
 
2
 
 
 
3p
 
1
 
 mice were generated by crossing
TCliRAG
 
2
 
/
 
2
 
 
 
Ii
 
2
 
/
 
2
 
 
 
mice to triple peptide mice on a RAG
 
2
 
/
 
2
 
 
 
Ii
 
2
 
/
 
2
 
background. Mutant and transgenic mice were bred and main-
tained under specific pathogen-free conditions at the animal facil-
ity at the University of Washington.
 
Radiation Bone Marrow Chimeras.
 
Bone marrow cells col-
lected from the femurs and tibias of TCR transgenic mice were
washed several times in serum-free RPMI 1640 and 5
 
 3 
 
10
 
6
 
 cells
were injected into the tail vein of each lethally irradiated (950
rads) recipient. Chimeras were given antibiotic-containing water
and analyzed 6–10 wk after bone marrow transfer.
 
Abs and Peptides.
 
The following mAbs directed to mouse cell
surface antigens were purchased from BD PharMingen: anti-
 
CD4–PE (RM4-5); anti-CD4–peridinin chlorophyll protein
(PerCP) (RM4-5); anti-CD8a–FITC (53-6.7); anti-CD8a–allo-
phycocyanin (APC) (53-6.7); anti-TCR-
 
b
 
–PE (H57-597);
anti-TCR-
 
b
 
–PE (H57-597); anti-V
 
b
 
6–PE (RR4-7); anti-V
 
a
 
2–
biotin (B20.1); anti-CD69–FITC (H1.2F3); anti-CD5–FITC
(53-7.3); anti-CD2–biotin (RM2-5); anti-CD28–biotin (37.51);
anti-CD44–biotin (IM7); anti-L-selectin–biotin (MEL-14); anti-
LFA-1–FITC (2D7); anti-CD45RB–FITC (16A); and anti-Thy-
1.1–FITC (HIS51). Anti-CD3 (145-2C11) mAb was provided by
Dr. M. Bevan (University of Washington, Seattle, WA). The fol-
lowing peptide–MHC class II complex–specific mAbs were used:
YAe (E
 
a
 
52–68
 
:I-A
 
b
 
 [27, 28]); Y3P (I-A
 
b
 
, HB183; American Type
Culture Collection); 15G4 (murine class II–associated Ii peptide
[CLIP]:I-A
 
b
 
 [29; unpublished observations]); A8 (CD22:I-A
 
b
 
);
and H10 (Rab5:I-A
 
b
 
; unpublished observations). All peptides
were synthesized with a Synergy 432 (Applied Biosystems) auto-
mated peptide synthesizer using Fmoc chemistry and analyzed by
reverse-phase HPLC. The purity of peptides used was 
 
.
 
90%.
 
Flow Cytometry.
 
For four-color analyses, 
 
z
 
5 
 
3
 
 10
 
5
 
 cells were
incubated on ice for 30 min with PE–, PerCP–, APC–, and bi-
otin–conjugated Abs, washed in PBS containing 1% FCS (Life
Technologies) and 0.1% sodium azide, and incubated with fluo-
rescein-avidin D (Vector Laboratories) for an additional 30 min
on ice. Labeled cells were washed and analyzed on a FACScan™
or FACScalibur™ flow cytometer (Becton Dickinson) using
CELLQuest™ and ReproMac software.
 
T Cell Assays.
 
To detect expression of specific peptides on
splenocytes from various mouse strains, we used T cell hybrid-
omas specific for I-E
 
a
 
52–68
 
, IgM
 
377–392
 
, 
 
b
 
2-microgobulin (
 
b
 
2m)
 
48–58
 
,
CD22
 
25–39
 
, and Rab5
 
86–101
 
 peptides presented on I-A
 
b
 
 (30).
Titrated numbers of splenocytes were incubated with 10
 
5
 
 T cell
hybrids for 18–20 h. IL-2 production was measured with the
IL-2–dependent HT-2 cell line in a colorimetric Alamar blue assay.
 
Calcium Flux.
 
Freshly isolated thymocytes were resuspended
at 10
 
7
 
 cells per milliliter in media (DMEM/3% FCS) containing 5
 
m
 
g of Indo-1-AM (Sigma-Aldrich) and incubated for 1 h at
37
 
8
 
C. Light exposure was minimized to prevent photobleaching.
Cells were then washed and surface-labeled for flow cytometry
with anti-CD4–PE and anti-CD8–FITC mAbs. Labeled thy-
mocytes were washed and resuspended in warm media at 2 
 
3
 
 10
 
6
 
cells/ml. Antigen-presenting cells were B6 splenocytes incubated
with various concentrations of peptide at 37
 
8
 
C for 3 h, washed,
and resuspended in warm media at 2 
 
3
 
 10
 
6
 
 cells/ml. For TCR
stimulation, 10
 
6
 
 labeled thymocytes were gently mixed with 10
 
6
 
APC and the sample was applied to a FACS Vantage™ (Becton
Dickinson) for 45 s to measure the basal intracellular concentra-
tion. The sample was then centrifuged for 8 s at 16,000 
 
g
 
 to max-
imize cell contacts, reapplied to the machine, and read for a fur-
ther 7 min. Changes in intracellular calcium were assessed over
time as the ratio of calcium-bound (FL5) to calcium-unbound
(FL4) Indo-1 fluorescence. Calcium flux data for gated CD4
 
1
 
CD8
 
1
 
 thymocytes was analyzed using FlowJo (Tree Star) soft-
ware.
 
Thymocyte Deletion Assay.
 
Total thymocytes from the indi-
cated strains of TCli mice were incubated overnight at 37
 
8
 
C in
the presence of B6 LPS blasts cultured with varying doses of hu-
man CLIP (hCLIP) peptide. After 18 h, cells were washed and
stained with anti-CD4–PerCP, anti-CD8–APC, anti-V
 
b
 
6–PE,
and anti-CD69–FITC for four-color flow cytometric analysis of
thymocyte coreceptor dulling as described above. After drawing a
tight-live gate, viable DP thymocytes remaining were calculated
as a percent of the starting proportion of CD4
 
hi
 
CD8
 
hi
 
 cells in the
indicated DP gate. 
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Results
 
Generation of Mice Expressing Limited Self-Peptide Reper-
toires.
 
First we wished to determine whether immature
thymocytes are capable of perceiving signals from nonse-
lecting intrathymic self-peptide–MHC complexes by ana-
lyzing hCLIP/I-A
 
b
 
–specific TCli TCR transgenic thy-
mocytes developing in the presence of a wild-type versus
altered repertoire of self-peptides that precluded positive
selection. We showed previously that TCli CD4
 
1
 
 T cells
are selected relatively poorly, apparently due to competi-
tion among TCli thymocytes for selecting peptide–MHC
class II complexes that are available in limited abundance in
the thymus (25). Nevertheless, we noticed that most DP
thymocytes in TCli mice have uniformly upregulated the
CD69 and CD5 markers associated with positive selection
(data not shown), a phenomenon which has been observed
in other TCR transgenic mice (11). The upregulated ex-
pression of these molecules on TCli DP thymocytes occurs
only in the presence of diverse MHC class II–bound pep-
tides on a wild-type selecting background, but not on the
nonselecting Ii-null (Ii
 
2
 
/
 
2
 
) background. However, these
markers do not reflect commitment of DP thymocytes to
the CD4 SP lineage as assessed by termination of CD8 pro-
tein synthesis and downregulation of RAG expression (data
not shown). Therefore, it is possible that upregulated
CD69 and CD5 expression on TCli DP thymocytes arises
from TCR engagement with self-peptides that do not pro-
mote positive selection.
To test this hypothesis, we analyzed the development of
TCli thymocytes in thymic environments that displayed
skewed repertoires of self-peptides yet maintained normal
levels of class II expression. Previously, we reported a strat-
 
egy for generating mice with different arrays of self-peptides
on class II molecules that are expressed at a wild-type level
(7). This involved reconstitution of murine Ii-deficient (Ii
 
2
 
/
 
2
 
)
mice and mice doubly deficient for both Ii and H-2M
(Ii
 
2
 
/
 
2
 
M
 
2
 
/
 
2
 
) with a human genomic Ii transgene construct
containing an embedded high affinity I-A
 
b
 
–binding peptide
in place of the CLIP region that associates with class II. We
have generated three such constructs, each containing a dif-
ferent, naturally occurring I-A
 
b
 
 peptide (E
 
a
 
52–68
 
, CD22
 
25–39
 
,
and Rab5
 
86–101
 
; unpublished observations). For this
study, we created mice that overexpress all three peptides
by coinjection of the three constructs into fertilized zygotes.
The triple peptide mice were bred to the Ii
 
2
 
/
 
2
 
 (3p/Ii
 
2
 
/
 
2
 
) or
Ii
 
2
 
/
 
2
 
M
 
2
 
/
 
2
 
 
 
(3p/Ii
 
2
 
/
 
2
 
M
 
2
 
/
 
2
 
) background. Both 3p/Ii
 
2
 
/
 
2
 
 and
3p/Ii
 
2
 
/
 
2
 
M
 
2
 
/
 
2 mice exhibit wild-type levels of class II ex-
pression and similarly high expression of all three transgene-
encoded peptides as detected by complex-specific Abs and
T cell assays using endogenous peptide-specific T cell hy-
brids (Fig. 1). A small fraction of the class II molecules in
3p/Ii2/2 mice do not display the transgene-encoded pep-
tides but present a diverse set of endogenous peptides such
as those derived from IgM and b2m (Fig. 1 B). However,
when the triple peptide transgenes are expressed on the Ii2/2
M2/2  background, the diversity of such “background”
peptides appears to be reduced, as reflected by our inability
to detect the IgM and b2m peptides by specific T cell hy-
brids (Fig. 1 B). Therefore, these mice provide thymic en-
vironments with peptide repertoires that are limited to pre-
dominant expression of three peptides combined with low
levels of a presumably more or less diverse set of other en-
dogenous peptides.
Figure 1. Splenocytes from
3p/Ii2/2 and 3p/Ii2/2M2/2 tri-
ple peptide transgenic mice
present a limited repertoire of
endogenous peptides. (A) High
surface expression of I-Ab–bound
Ea, CD22, and Rab5-derived
peptides as indicated by flow cy-
tometric analysis of splenocytes
using peptide:I-Ab complex–spe-
cific Abs. Splenocytes from wild-
type B6 (top), 3p/Ii2/2 (bottom,
thin lines), and 3p/Ii2/2M2/2
(bottom, thick lines) mice were
stained with Y3P (I-Ab–specific),
15G4 (mouse CLIP:I-Ab–spe-
cific), YAe (Ea:I-Ab–specific),
A8 (CD22:I-Ab–specific), or H10
(Rab5:I-Ab–specific) Ab to assess
surface class II/peptide expres-
sion. (B) 3p/Ii2/2M2/2 spleno-
cytes exhibit a further reduced
endogenous peptide repertoire
relative to 3p/Ii2/2 splenocytes.
Titrated numbers of splenocytes
from B6 (m), H-2M2/2 (s), 3p/
Ii2/2 ( u), and 3p/Ii2/2M2/2
(j) mice were used to stimulate T cell hybridomas specific for Rab5, CD22, IgM, or b2m peptides. IL-2 production by T cells was assessed by screening
assay supernatants with the Alamar Blue colorimetric assay using the IL-2–dependent HT-2 cell line and measuring the OD570/600 absorbance.1182 Tuning of T Cell Reactivity by Self-Peptide–MHC Complexes
Intrathymic Self-Peptides Induce Altered Expression Levels of
Accessory Molecules on DP Thymocytes Independent of Positive
Selection. First we constructed bone marrow chimeras to
determine whether upregulation of CD69 and CD5 on
TCR transgenic DP cells and maturation into CD4 SP
thymocytes could be mediated by either the major or
minor peptides expressed in 3p/Ii2/2 and 3p/Ii2/2M2/2
mice. Bone marrow from RAG-deficient TCli mice
(TCliRAG2/2) was transferred into lethally irradiated wild-
type B6, 3p/Ii2/2, and 3p/Ii2/2M2/2 hosts. As predicted,
we found that TCli®B6 chimeras exhibit normal positive
selection of TCli CD41 T cells and upregulated expression
of CD69 and CD5 on DP thymocytes similar to that seen
in unmanipulated TCli mice (Fig. 2 A, and data not
shown). In contrast, positive selection of TCli T cells is
completely blocked at the DP stage of development in both
3p/Ii2/2 and 3p/Ii2/2M2/2 hosts. However, interestingly,
the DP thymocytes in these mice present a range of CD69
and CD5 expression (Fig. 2 B). The level of upregulation of
these markers on the TCli thymocytes appears to parallel
the endogenous peptide diversity expected in the different
hosts. TCli DP thymocytes developing in wild-type B6
mice express the highest levels of CD69 and CD5 and ex-
hibit progressively lower expression of these markers in 3p/
Ii2/2 and 3p/Ii2/2M2/2 mice. DP thymocytes from
TCli®3p/Ii2/2M2/2 chimeras exhibit the lowest levels of
these markers comparable to those seen on DP cells of
wild-type mice and Ii-deficient TCli mice (data not
shown). These results demonstrate that increased expression
of CD69 and CD5 on DP thymocytes can occur in the ab-
sence of positive selection and the relative levels of these
markers appear to be influenced by the diversity of endoge-
nous thymic peptide–MHC ligands. Since a wide array of
different self-peptides appears to be necessary for maximal
expression of these molecules, distinct peptides may induce
different levels of CD69/CD5 upregulation depending on
the avidity of the TCR interaction with these ligands.
It was possible that the presentation of a wild-type, di-
verse set of self-peptides on bone marrow–derived antigen-
presenting cells might play a role in the upregulation of
CD69 and CD5 seen in the DP thymocytes of the
TCli®3p/Ii2/2 chimeras. Although the graded expression
of these markers in the different chimeras makes it unlikely,
TCR engagement with the selecting ligand on bone mar-
row–derived cells rather than on thymic epithelial cells may
upregulate CD69 and CD5 without promoting positive se-
lection. To exclude this possibility, we bred 3p/Ii2/2 mice
to TCliRAG2/2 mice to generate TCliRAG2/2Ii2/23p1
mice and analyzed T cell development in these animals.
We also examined TCliRAG22/2Ii2/23p2 littermates as
controls in these experiments. As seen in the TCli®3p/Ii2/2
chimeras, positive selection of CD41 T cells is abrogated in
TCliRAG2/2Ii2/23p1 mice and TCliRAG2/2Ii2/23p2 lit-
termates (Fig. 3 A). Nevertheless, CD69 and CD5 are up-
regulated in TCliRAG2/2Ii2/23p1 DP thymocytes to a
level that is intermediate between that in TCliRAG2/2 and
TCliRAG2/2Ii2/23p2 DP thymocytes (Fig. 3 B). In-
creased expression of these markers is less dramatic than
seen in the chimeras, but the overall pattern remains the
same. Increased expression of CD2 and LFA-1 was also ob-
served in TCliRAG2/2Ii2/23p1 DP thymocytes, whereas
expression levels of the transgenic TCR (Vb6) remained
constant on selecting and nonselecting backgrounds (Fig. 3
B, and data not shown). Other molecules such as CD28,
CD44, and L-selectin were upregulated only in TCli DP
thymocytes on a normal selecting background, but not in
TCliRAG2/2Ii2/23p1 or TCliRAG2/2Ii2/23p2 DP thy-
mocytes (data not shown). These results show that, despite
the lack of positive selection, DP thymocytes can receive
signals from thymic self-peptides that alter the surface ex-
pression levels of several T cell accessory molecules. The
magnitude of upregulation of these molecules is propor-
tional to the endogenous peptide diversity.
MHC-dependent Changes in Cell Surface Marker Phenotype
in Preselection DP Thymocytes from Wild-Type Mice. Next
we determined whether similar ligand-dependent upregu-
Figure 2. Upregulation of CD69 and CD5 in TCli DP thymocytes can
occur in the absence of positive selection. (A) CD4/CD8 flow cytometry
density plots for B6 mice, TCliRAG2/2®B6, TCliRAG2/2®3p/Ii2/2,
and TCliRAG2/2®3p/Ii2/2M2/2 bone marrow chimeras, with per-
centages of cells falling into each gate indicated. (B) Flow cytometry his-
tograms of CD69 and CD5 expression on gated DP thymocytes from the
indicated mice. Three chimeras of each type were analyzed yielding simi-
lar FACS® profiles.1183 Wong et al.
lation of the same molecules could be observed on normal
polyclonal DP thymocytes in which the majority of cells
are not positively selected. DP thymocytes from B6 mice
do indeed exhibit higher expression of CD69, CD5, and
CD2 than DP thymocytes in MHC class I and class II dou-
ble-deficient (I2/2II2/2) mice, whereas expression of other
molecules such as CD28 and CD45RB are identical (Fig.
4). This result demonstrates that all immature DP thy-
mocytes from normal mice can perceive signals from MHC
ligands that upregulate several accessory molecules before
positive selection. Although it is unclear whether this is de-
pendent on specific peptides, the results with the TCli
TCR suggest that specific peptides are involved in this up-
regulation.
Surface CD5 and CD2 Expression Levels Correlate with
Thymocyte Sensitivity to Antigen. Studies of CD5 function
in thymocytes have suggested that it plays a role in dampen-
ing signals delivered through the TCR, as thymocytes from
CD52/2 mice are hyperresponsive to TCR stimulation and
the selection of T cells in such mice is altered in a manner
consistent with enhanced TCR signaling (31). CD5 func-
tion is believed to be related to its constitutive association
with the phosphotyrosine phosphatase src homology 2 do-
main–bearing protein tyrosine phosphatase 1 (SHP-1)
through an immunoreceptor tyrosine-based inhibitory–like
motif (ITIM), which may negatively regulate phosphoryla-
tion of substrates involved in the TCR signaling pathway
(32). Similarly, certain strains of TCR transgenic mice defi-
cient in CD2 exhibit increased positive selection, suggesting
that CD2 may also negatively regulate TCR signaling in
thymocytes (33). Therefore, we tested whether the in-
creased levels of CD5 and CD2 observed on TCliRAG2/2
and TCliRAG2/2Ii2/23p1 DP thymocytes correlated with
decreased sensitivity to TCR stimulation. To characterize
the responsiveness of DP thymocytes to TCR stimula-
tion, we assessed the magnitude of calcium flux in thy-
mocytes upon stimulation with peptide-pulsed syngeneic
splenocytes. TCliRAG2/2, TCliRAG2/2Ii2/2  3p1, and
TCliRAG2/2Ii2/23p2 thymocytes expressing high, inter-
mediate, and low levels of CD5 at the DP stage, respec-
tively, were loaded with the Ca21-binding fluorescent dye
Indo-1, stimulated with B6 splenocytes, pulsed with titrated
Figure 3. DP thymocytes in
TCliRAG2/2Ii2/23p1 mice are not posi-
tively selected but exhibit increased ex-
pression of CD5, CD2, and CD69. (A)
CD4/CD8 flow cytometry density plots
for wild-type B6, TCliRAG2/2,
TCliRAG2/2Ii2/23p1, and TCliRAG2/2
Ii2/23p2 mice, with percentages of cells
falling into each quadrant indicated. (B)
Flow cytometry histogram overlays of
CD5, CD2, CD69, and TCR Vb6 ex-
pression on gated DP thymocytes from
the indicated mice. Two mice of each
strain were analyzed yielding similar
FACS® profiles. Thymic cellularity for all
mice analyzed was in the normal range
expected (1–3 3 108).
Figure 4. The majority of
polyclonal DP thymocytes from
normal mice have received
MHC-dependent signals that
upregulate surface levels of spe-
cific accessory molecules inde-
pendently of positive selection.
Shown are histogram overlays of
expression of the indicated mol-
ecules on DP thymocytes from
wild-type B6 versus MHC class
I and class II double-deficient
(I2/2II2/2) mice.1184 Tuning of T Cell Reactivity by Self-Peptide–MHC Complexes
amounts of the cognate hCLIP peptide, and analyzed by
FACS® for the degree of Ca21 flux expressed as the ratio of
Ca21-bound to unbound Indo-1. It should be noted that
despite the difference in CD5 and CD2 expression, TCR
levels are similar between DP thymocytes from all three
strains of mice (Fig. 3 B). In agreement with our prediction,
we found that DP thymocytes from TCliRAG2/2Ii2/2
mice show the greatest Ca21 flux, followed by DP thy-
mocytes from TCliRAG2/2Ii2/23p1 mice, and finally
TCliRAG2/2 DP thymocytes (Fig. 5 A). At lower peptide
concentrations, the extent of flux is decreased for all DP
populations, yet the difference in magnitude between the
DP thymocytes remains obvious (Fig. 5 A).
We also examined the sensitivity of TCli DP thymocytes
to deletion by the cognate ligand in vitro. In this assay, thy-
mocytes from TCliRAG2/2, TCliRAG2/2Ii2/23p1, and
TCliRAG2/2Ii2/23p2 mice were cultured overnight with
varying doses of hCLIP presented by normal B6 splenic
LPS blasts and assessed for the extent of CD4/CD8 core-
ceptor dulling by flow cytometry as a measure of deletion.
The results are shown as the percentage of the starting pro-
portion of viable coreceptorhi DP thymocytes remaining at
the different peptide concentrations. In agreement with the
calcium flux data, we observed that TCliRAG2/2 DP thy-
mocytes, which expressed the highest levels of CD5 and
CD2, show the greatest resistance to in vitro deletion (Fig.
5 B). In contrast, TCliRAG2/2Ii2/23p1 and TCliRAG2/2
Ii2/23p2 DP thymocytes, which express lower levels of
CD5 and CD2, exhibit significant coreceptor dulling
even at the lowest concentration of antigen. Consistent
with their higher expression levels of CD5 and CD2,
TCliRAG2/2Ii2/23p1 DP thymocytes are slightly less sen-
sitive to deletion than TCliRAG2/2Ii2/23p2 DP thy-
mocytes. Taken together with the calcium flux data, these
results indicate that the sensitivity of immature DP thy-
mocytes to TCR stimulation is modulated by the makeup
of the self-peptide repertoire and appears to be inversely
proportional to the expression levels of CD5 and CD2.
Discussion
Thymic self-peptide–MHC complexes play a critical role
in positive and negative selection of developing T cells. It
has been traditionally viewed that TCR engagement with
specific endogenous peptides in the thymus will lead to one
or the other of these events. However, what has not been
clear is whether thymocyte interactions with self-peptides
that are below the avidity threshold for positive and nega-
tive selection have any significant biological effects. Since a
continuum of TCR–ligand avidities are possible with a di-
verse self-peptide repertoire, it can be readily envisioned
that thymocytes may encounter peptide–MHC complexes
that fall just outside the window of positive selection. Also,
previous studies have suggested that positive selection may
involve multiple TCR engagements with intrathymic
ligands, but it has not been clear whether the same ligands
or different ones are associated with each “hit.”
In this study, we have demonstrated for the first time
that immature DP thymocytes in both normal and TCR
transgenic animals can perceive signals delivered by thymic
Figure 5. TCR sensitivity to cognate
ligand is inversely proportional to CD5/
CD2 expression on DP thymocytes. (A)
TCli DP thymocytes developing in the
presence of reduced self-peptide diversity
flux calcium greater than TCli DP thy-
mocytes from a wild-type selecting back-
ground. The ratio of calcium-bound to cal-
cium-free Indo-1 is shown as the FL5/FL4 fluorescence ratio after Indo-loaded
thymocytes from TCliRAG2/2, TCliRAG2/2Ii2/23p1, or TCliRAG2/2Ii2/23p2 mice
were stimulated with syngeneic wild-type splenocytes pulsed with various concentrations
of hCLIP. Breaks in the traces correspond to the time during which thymocytes and an-
tigen-presenting cells were centrifuged together to form conjugates before resumed anal-
ysis on the flow cytometer. (B) TCli DP thymocytes developing in the presence of re-
duced self-peptide diversity are more sensitive to in vitro deletion by cognate peptide.
Thymocytes from TCliRAG2/2, TCliRAG2/2Ii2/23p1, or TCliRAG2/2Ii2/23p2
mice were cultured overnight with B6 LPS blasts presenting varying doses of hCLIP and
analyzed for coreceptor dulling by flow cytometry as a measure of deletion. Data are pre-
sented as the percentage of starting proportional of viable coreceptorhi DP thymocytes re-
maining after culture with the indicated doses of peptides.1185 Wong et al.
self-peptide–MHC ligands in vivo that appear to fall below
the threshold for positive selection. These signals are suffi-
cient to induce alterations in the expression of several ac-
cessory molecules that can regulate TCR signaling. We
also show that DP thymocytes maturing in thymi harboring
distinct self-peptide repertoires exhibit differential TCR
sensitivity to antigen in a manner that correlates with the
altered expression of negative regulatory molecules such as
CD5 and CD2 in the various backgrounds analyzed.
It has been shown that CD5 expression can be regulated
by the avidity of the selecting ligand interaction as a means
of fine tuning the TCR signaling response in developing T
cells (11). Our findings reveal that, in addition to the se-
lecting ligand(s), a broader spectrum of self-peptides than
previously thought is able to interact with the TCR of im-
mature thymocytes at the DP stage of T cell development
and cause alterations in thymocyte surface phenotype and
TCR sensitivity. TCR engagement with these intrathymic
peptide–MHC ligands results in a signal that induces cells
to upregulate not just CD5, but also CD69, CD2, and per-
haps other accessory molecules, but does not promote lin-
eage commitment. Importantly, since greater upregulation
of these molecules is seen on more diverse peptide–MHC
backgrounds, the avidity with which these peptides engage
the TCR likely influences the extent of alteration in sur-
face marker expression levels that occurs. In our model, full
positive selection to the SP lineage would require TCR
engagement with an even more specific subset of self-pep-
tides that may have higher affinity for the TCR and induce
higher levels of CD69, CD5, and CD2 expression. Obvi-
ously, peptides with affinities higher than that allowed for
positive selection would induce deletion. Thus, distinct sets
of peptides on cortical thymic epithelial cells can be sensed
by developing thymocytes and induce variable maturational
changes in these cells. In this way, TCR sensitivity can be
adjusted via a rheostat-like mechanism whereby self-pep-
tides variably tune the levels of TCR signaling modifying
molecules such as CD5 and CD2.
It may be argued that quantitative differences in signaling
delivered by the positively selecting ligand(s) may induce
distinct outcomes (e.g., alteration in cell surface phenotype
versus commitment to the SP lineage). For example, the
CD69/CD5/CD2 upregulation on DP thymocytes in the
absence of positive selection seen in the TCli®3p/Ii2/2
chimeras and TCliRAG2/2Ii2/23p1 mice may simply re-
flect TCR interaction with decreased amounts of the se-
lecting ligand still present in these mice that would nor-
mally induce complete maturation at a higher density.
Although this is a valid explanation, it seems unlikely be-
cause the uniform upregulation of these markers observed
suggests that most transgenic DP thymocytes have received
a TCR signal. If the upregulation resulted from TCR in-
teraction with low levels of the selecting ligand, we would
instead expect to see a bimodal distribution of expression of
these molecules, reflecting competition for low levels of
the putative ligand. Our results instead suggest that the
ligands responsible for the CD69/CD5/CD2 upregulation
are expressed fairly abundantly.
It is also highly unlikely that the increased expression of
CD69, CD5, and CD2 on DP thymocytes in the absence
of lineage commitment is due to negative selection occur-
ring in TCliRAG2/2Ii2/23p1 mice. In deletion assays, we
consistently observe much higher elevation of CD69 on
TCli DP thymocytes upon addition of the cognate peptide
than observed on DP thymocytes of TCliRAG2/2Ii2/23p1
mice or TCli®3p/Ii2/2 chimeras (data not shown).
The peptide-specific upregulation of CD5 and CD2 on
DP thymocytes appears related to decreased TCR sensitiv-
ity, since we find that DP thymocytes expressing higher
levels of CD5/CD2 exhibit decreased reactivity to cognate
ligand compared with those bearing lower levels of CD5/
CD2. Although this evidence is correlative, it agrees with
reports suggesting that CD5 and CD2 negatively regulate
TCR signaling (31–34). We speculate that CD5/CD2 up-
regulation in thymocytes in response to intrathymic pep-
tide ligands serves to modulate TCR responsiveness by
raising the activation threshold such that emerging T cells
are not overtly reactive to the self-peptide repertoire. Such
a mechanism may explain the decreased sensitivity of thy-
mocytes upon maturation observed by several investigators
(18, 19, 35). In those reports, T cell maturation from the
DP to SP lineage was shown to be accompanied by re-
duced sensitivity to weak agonist ligands but not to strong
agonists, whereas we observe less responsiveness to the
cognate agonist ligand in DP thymocytes that develop in
the presence of an increased diversity of self-peptides.
However, the comparisons being made are different since
those studies do not examine DP thymocytes on nonselect-
ing versus selecting environments. Nevertheless, the dis-
similar results may perhaps be due to the different TCRs
analyzed and the different assays of TCR sensitivity em-
ployed. In those studies, TCR responsiveness was primarily
measured by CD69 upregulation, while we assessed reac-
tivity by calcium flux and in vitro deletion assays.
A theoretic model of dynamic tuning of activation
thresholds during thymocyte development has been ele-
gantly described previously (36), and a role for CD5 in this
process is supported by the finding that CD5 expression
levels on mature T cells parallel the signaling intensity or
avidity of the positively selecting TCR-peptide–MHC in-
teraction (11). However, it has not been previously re-
ported that TCR interactions with peptides other than
those involved in positive or negative selection are capable
of modulating expression of CD5 expression. We show
that an apparently broad range of peptides may interact
with the TCR of developing DP thymocytes and modify
the expression of not only CD5, but also CD2, CD69, and
likely many other molecules that regulate TCR responsive-
ness. Because we can show that these molecules are upreg-
ulated proportionally to the self-peptide diversity, our re-
sults support an analogue process of TCR tuning in which
the expression of various accessory molecules is variably
regulated, rather than switched on or off. Thus, depending
on the strength of the TCR–peptide interactions encoun-
tered in the thymus, CD5 and CD2 expression on imma-
ture thymocytes may be upregulated to different extents in1186 Tuning of T Cell Reactivity by Self-Peptide–MHC Complexes
order to establish a baseline of responsiveness that precludes
reactivity to self-ligands. The thymic environment exhibit-
ing greater self-peptide diversity promotes higher CD5 ex-
pression since it would presumably include peptide–MHC
complexes that can engage the TCR with higher avidity.
Importantly, this mechanism would also progressively
limit the number of peptides from which the developing
thymocyte may perceive signals, resulting in gradually in-
creasing peptide specificity for the final stages of positive
selection. Increasing desensitization of thymocytes as a con-
sequence of multiple TCR engagement with low avidity
ligands leading to CD5 upregulation may progressively in-
crease the affinity thresholds that define positive and nega-
tive selection. One intriguing possibility that this notion
raises is that the selecting peptides involved in the late steps
of development may differ for a given TCR depending on
its previous history of encounters with intrathymic peptide
ligands. The increased TCR signaling thresholds set during
thymocyte maturation results in the generation of peptide-
specific, rather than peptide-promiscuous, T cells.
Our data suggest that, through modulation of regulatory
molecules upon TCR interaction with the continuum of
thymic self-peptides, T cells establish cellular activation
thresholds during maturation in the thymus to prevent re-
activity to self. However, the self-peptide repertoire in the
periphery may not mirror that of the thymus, especially in
light of data showing that the expression of cathepsins reg-
ulating antigen processing are differentially regulated in
thymic epithelial cells versus bone marrow–derived anti-
gen-presenting cells (37). Thus, T cells may require further
tuning of TCR sensitivity to the self-peptide repertoire in
the periphery. We have preliminary data showing that sev-
eral T cell accessory molecules such as CD2, CD5, and
CD28 are altered in splenic CD41 T cells compared with
thymic CD4 SP thymocytes, suggesting that the adjustment
of TCR sensitivity may continue in mature T cells in the
periphery. We also found that adoptive transfer of TCli
CD41 T cells into hosts expressing altered sets of self-pep-
tides results in changes in CD5 expression. This suggests
that TCR tuning through alterations in signaling regulatory
molecules may not be fixed in the thymus but may be a
continuous process throughout the lifetime of the T cell.
Further experiments should determine whether this hy-
pothesis is valid.
In conclusion, we have shown that ab TCR1 imma-
ture thymocytes can sense signals from intrathymic self-
peptide–MHC complexes that initiate alterations in
surface phenotype and TCR sensitivity independently
of positive selection. This is likely to be a critical pro-
cess by which developing T cells are tuned to ignore
self-peptides. This scenario is appealing since it ensures
that T cell reactivity is adjusted according to the
makeup of the self-peptide repertoire such that all
cross-reacting self-peptides that may potentially be acti-
vating ligands become inert ligands. The outcome of
this process is a T cell pool that is tolerant to the self-
peptide repertoire while remaining poised to deal with
foreign antigen.
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